References

Australian Commission on Safety and Quality in Health Care. Management of peripheral intravenous catheters clinical care standard. 2021a. https://tinyurl.com/2p86r5zd (accessed 11 January 2022)

Australian Commission on Safety and Quality in Health Care. Implementation guide for the surveillance of staphylococcus aureus bloodstream infection. 2021b. https://tinyurl.com/2bkdjexu

Australian Institute of Health and Welfare. My hospitals. 2021. https://www.aihw.gov.au/myhospitals (accessed 11 January 2022)

Bitmead J, Oliver G. A safe procedure: best practice for intravenous peripheral cannulation. Br J Nurs. 2018; 27:S1-S8 https://doi.org/10.12968/bjon.2018.27.Sup2.S1

Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018; 16:(3)143-155 https://doi.org/10.1038/nrmicro.2017.157

Carr PJ, Rippey JC, Cooke ML Development of a clinical prediction rule to improve peripheral intravenous cannulae first attempt success in the emergency department and reduce post insertion failure rates: the Vascular Access Decisions in the Emergency Room (VADER) study protocol. BMJ Open. 2016; 6:(2) https://doi.org/10.1136/bmjopen-2015-009196

Carr PJ, Higgins NS, Cooke ML, Rippey J, Rickard CM. Tools, clinical prediction rules, and algorithms for the insertion of peripheral intravenous catheters in adult hospitalized patients: a systematic scoping review of literature. J Hosp Med. 2017; 12:(10)851-858 https://doi.org/10.12788/jhm.2836

El Aila NA, Al Laham NA, Ayesh BM. Nasal carriage of methicillin resistant Staphylococcus aureus among health care workers at Al Shifa hospital in Gaza Strip. BMC Infect Dis. 2017; 17:(1) https://doi.org/10.1186/s12879-016-2139-1

Gosbell IB. Diagnosis and management of catheter-related bloodstream infections due to Staphylococcus aureus. Intern Med J. 2005; 35:S45-S62 https://doi.org/10.1111/j.1444-0903.2005.00979.x

Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011; 9:(4)244-253 https://doi.org/10.1038/nrmicro2537

Hawkins T, Greenslade JH, Suna J Peripheral intravenous cannula insertion and use in the emergency department: an intervention study. Acad Emerg Med. 2018; 25:(1)26-32 https://doi.org/10.1111/acem.13335

McHugh ML. The chi-square test of independence. Biochem Med (Zagreb). 2013; 23:(2)143-149 https://doi.org/10.11613/bm.2013.018

Mermel LA. Short-term peripheral venous catheter-related bloodstream infections: a systematic review. Clin Infect Dis. 2017; 65:(10)1757-1762 https://doi.org/10.1093/cid/cix562

Mitchell BG, Shaban RZ, MacBeth D, Wood CJ, Russo PL. The burden of healthcare-associated infection in Australian hospitals: A systematic review of the literature. Infect Dis Health. 2017; 22:(3)117-128 https://doi.org/10.1016/j.idh.2017.07.001

Intravascular access devices (IVAD) – infection prevention and control.Sydney: NSW Health; 2019

Queensland Health. Intravascular device management. 2015. https://tinyurl.com/2p9ec8wu (accesssed 12 January 2021)

Rhodes D, Cheng AC, McLellan S Reducing Staphylococcus aureus bloodstream infections associated with peripheral intravenous cannulae: successful implementation of a care bundle at a large Australian health service. J Hosp Infect. 2016; 94:(1)86-91 https://doi.org/10.1016/j.jhin.2016.05.020

Ruegg L, Faucett M, Choong K. Emergency inserted peripheral intravenous catheters: a quality improvement project. Br J Nurs. 2018; 27:S28-S30 https://doi.org/10.12968/bjon.2018.27.14.S28

Stuart RL, Cameron DR, Scott C Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia: more than 5 years of prospective data from two tertiary health services. Med J Aust. 2013; 198:(10)551-553 https://doi.org/10.5694/mja12.11699

Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28:(3)603-661 https://doi.org/10.1128/CMR.00134-14

Turnidge JD, Kotsanas D, Munckhof W Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust. 2009; 191:(7)368-373 https://doi.org/10.5694/j.1326-5377.2009.tb02841.x

Wertheim HF, Melles DC, Vos MC The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005; 5:(12)751-762 https://doi.org/10.1016/S1473-3099(05)70295-4

Reducing the prevalence of antecubital fossa peripheral intravenous cannulation

27 January 2022
11 min read
Volume 31 · Issue 2

Abstract

Observational studies have found that placement of peripheral intravenous cannulas (PIVCs) in the antecubital fossa (ACF) is associated with increased risks of infection, including healthcare-associated Staphylococcus aureus bacteraemia (HA-SAB). Avoiding placement of the PIVC in the ACF area along with other preventive measures such as aseptic technique, staff education on documentation, standardised insertion packs and alerts for timely removal, may reduce the overall risk of acquiring an HA-SAB. Aim: To implement a multimodal awareness programme on ACF cannulas and the risk of infection, and to reduce PIVC-associated HA-SAB in one hospital in Australia. Method: The authors performed a baseline digital survey to identify root causes for clinical decision making related to PIVCs and to raise awareness of the project. The authors performed weekly audits and provided feedback on four key wards over 12 weeks. Simple linear regression was used to look at the trend of ACF cannulation rates over time. HA-SAB rates were calculated per 10 000 occupied bed days. Findings: Improved insertion documentation was observed during the intervention period. The ACF cannulation rates decreased by 0.03% per day during the study, although this did not quite reach statistical significance (P=0.06). There were no PIVC-associated SAB events during the intervention period. The SAB rates decreased by 0.02% per day over the period of the study.

Peripheral intravenous cannulas (PIVCs) are among the most used devices in hospitalised patients (Carr et al, 2017; Australian Commission on Safety and Quality in Healthcare (ACSQH), 2021a). Optimal management of PIVCs is important to reduce the risks of infection, including healthcare-associated Staphylococcus aureus (Staph. aureus) bacteraemia (HA-SAB) bloodstream infections (BSIs) (New South Wales (NSW) Ministry of Health, 2019). PIVCs account for almost a quarter of the HA-SABs in Australia (Rhodes et al, 2016) ahead of surgical site infections and infections caused by central venous catheter and other indwelling devices (Rhodes et al, 2016; ACSQH, 2021b).

On insertion, a PIVC breaches and traumatises the skin, the natural barrier to foreign objects and, potentially, provides a conduit for microorganisms to form biofilms on the catheter (Grice and Segre, 2011; Byrd et al, 2018). When bacteria colonise the external surface of the catheter, there is potential for them to migrate down the length of the catheter and enter the bloodstream (Mermel, 2017; Bitmead and Oliver, 2018). Bacteria can also enter the bloodstream through the contamination of the hub/lumen of the PIVC (Mermel, 2017; NSW Ministry of Health, 2019; ACSQH, 2021a).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content